Skip to main content
Premium Trial:

Request an Annual Quote

Toronto Institute Collaborates with AB Sciex on New Mass Spec Platform

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Proteomics tools developer AB Sciex said today that it is collaborating with Mount Sinai Hospital's research institute in Toronto to study proteins involved in cancer, diabetes, and heart disease.

Mount Sinai's Samuel Lunenfeld Research Institute is using an emerging mass spectrometry platform that is being developed by AB Sciex to analyze complex protein interactions and modifications in the pathways and processes involved in cellular communication. AB Sciex said that the new platform "combines qualitative and quantitative analysis at high resolution, high speed, and high sensitivity with accurate mass."

The collaboration with the Lunenfeld scientists also will help AB Sciex develop new workflows and applications that will be available when the mass spec platform is launched sometime later this year.

"Through the development of workflows and applications, we will be able to deliver more effective ways of working that will be available on the industry's most unique mass spectrometry platform." AB Sciex VP and GM of Pharmaceuticals and Proteomics Dave Hicks said in a statement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.